NASDAQ · BLACU
Bellevue Life Sciences Acquisition Corp.
Financial Services · Shell Companies
$3.36
Down-$3.74 (-52.68%)
Updated Aug 13, 2026, 11:08 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.98M
- P/E ratio
- -0.84
- Dividend yield
- 0.00%
- 52-week range
- $3.36 – $13.71
- Volume
- 5.21K
- Avg. volume
- 5.03K
Price performance
BLACU price history
1M range · 0 trading sessions · Daily adjusted prices
BLACU does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest BLACU news
The latest Smart Investors Daily articles mentioning BLACU.
Stock researchCompany · Overview
BLACU research
Overview
Company profile and research snapshot.
Company profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
